Alteration of Serum Proteome in Levo-Thyroxine-Euthyroid Thyroidectomized Patients
Authors:
- Claudia LandiClaudia Landi
- Silvia CantaraSilvia Cantara
- Enxhi ShabaESEnxhi Shaba
- Lorenza VantaggiatoLVLorenza Vantaggiato
- Carlotta MarzocchiCMCarlotta Marzocchi
- Fabio MainoFMFabio Maino
- Alessio BombardieriABAlessio Bombardieri
- Alfonso CarleoACAlfonso Carleo
- Fabrizio Di GiuseppeFGFabrizio Di Giuseppe
- Stefania AngelucciStefania Angelucci
- Luca BiniLBLuca Bini
- Maria Grazia CastagnaMCMaria Grazia Castagna
Open Access
- 17 March 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (6) , 1676
Abstract
The monotherapy with levo-thyroxine (LT4) is the treatment of choice for patients with hypothyroidism after thyroidectomy. However, many athyreotic LT4-treated patients with thyroid hormones in the physiological range experience hypothyroid-like symptoms, showing post-operative, statistically significant lower FT3 levels with respect to that before total thyroidectomy. Since we hypothesized that the lower plasmatic FT3 levels observed in this subgroup could be associated with tissue hypothyroidism, here we compared, by a preliminary proteomic analysis, eight sera of patients with reduced post-surgical FT3 to eight sera from patients with FT3 levels similar to pre-surgery levels, and six healthy controls. Proteomic analysis highlights a different serum protein profile among the considered conditions. By enrichment analysis, differential proteins are involved in coagulation processes (PLMN-1.61, -1.98 in reduced vs. stable FT3, p < 0.02; A1AT fragmentation), complement system activation (CFAH + 1.83, CFAB + 1.5, C1Qb + 1.6, C1S + 7.79 in reduced vs. stable FT3, p < 0.01) and in lipoprotein particles remodeling (APOAI fragmentation; APOAIV + 2.13, p < 0.003), potentially leading to a pro-inflammatory response. This study suggests that LT4 replacement therapy might restore biochemical euthyroid conditions in thyroidectomized patients, but in some cases without re-establishing body tissue euthyroidism. Since our results, this condition is reflected by the serum protein profile.Keywords
This publication has 32 references indexed in Scilit:
- Role of the type 2 iodothyronine deiodinase (D2) in the control of thyroid hormone signalingBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid AssociationEndocrine Practice, 2012
- 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of HypothyroidismEuropean Thyroid Journal, 2012
- Molecular basis underlying the biological effects elicited by extremely low-frequency magnetic field (ELF-MF) on neuroblastoma cellsJournal of Cellular Biochemistry, 2011
- Proteome analysis of bronchoalveolar lavage in pulmonary langerhans cell histiocytosisJournal of Clinical Bioinformatics, 2011
- Psychological well‐being in patients on ‘adequate’ doses of l‐thyroxine: results of a large, controlled community‐based questionnaire studyClinical Endocrinology, 2002
- Components of the Fibrinolytic System Are Differently Altered in Moderate and Severe HypothyroidismThe Journal of Clinical Endocrinology & Metabolism, 2001
- The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and EClinical Endocrinology, 1997
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970